Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 61-70 of 249

Page
per page
  1. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  2. AT7519
    A5719 AT7519
    Target: Cyclin-Dependent Kinases
    Summary: Multi-CDK inhibitor
  3. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  4. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO
  5. CYC116
    A4125 CYC116
    Target: Aurora Kinases|FLT3|VEGFR
    Summary: Potent Aurora A/B inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
  6. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL
  7. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: Selective IGF-1R/IR inhibitor
      ≥42.6 mg/mL
  8. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  9. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  10. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL

Items 61-70 of 249

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 241item
  2. Natural Products 3item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 2item
Specificity
  1. Selective 152item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 10item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 17item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 11item
  5. Raf 8item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 8item
  9. AP-1 1 item
  10. FLT3 11item
  11. GSK-3 5item
  12. PLK 5item
  13. Chk 3item
  14. Eph Receptors 2item
  15. VEGFR 22item
  16. PDGFR 16item
  17. c-Kit 9item
  18. RET 2item
  19. IRAK 1 item
  20. Bromodomain-containing proteins(BRDs) 1 item
  21. Thymidylate Synthase 1 item
  22. p38 4item
  23. PKB 1 item
  24. Bcr-Abl 8item
  25. MEK 2item
  26. FGFR 8item
  27. Pim 3item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. MET 3item
  30. Src 13item
  31. Trk Receptors 1 item
  32. STAT 5item
  33. Estrogen and Related Receptors 1 item
  34. EGFR 15item
  35. Reverse Transcriptases 1 item
  36. ROCK 3item
  37. FAK 2item
  38. JAK 13item
  39. Syk 3item
  40. DNA-PK 6item
  41. AMPK 1 item
  42. Topoisomerases 7item
  43. Cytochrome P450 (CYP450) 1 item
  44. ErbB 3item
  45. DNA Methyltransferases 1 item
  46. ERK 3item
  47. c-MET 4item
  48. PKC 9item
  49. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  50. Lyn 1 item
  51. Pyk2 2item
  52. LRRK2 5item
  53. Insulin and Insulin-like Receptors 3item
  54. ALK 4item
  55. Sphingosine kinases (SphKs) 2item
  56. PKG 1 item
  57. PKA 3item
  58. Myosin light chain kinases (MLCKs) 1 item
  59. MK2 1 item
  60. Angiotensin-Converting Enzymes (ACEs) 1 item
  61. Tie-2 1 item
  62. RSK 2item
  63. phosphatases 1 item
  64. ATM/ATR 4item
  65. Farnesyl Diphosphate Synthases 1 item
  66. CK2 3item
  67. HIPK2 1 item
  68. HIPK3 1 item
  69. HIV Integrases 1 item
  70. P2X Receptors 1 item
  71. BLM 1 item
  72. HSV 1 item
  73. Synthases/Synthetases 2item
  74. MAGL 1 item
  75. Histamine H1 Receptors 1 item
  76. P110 1 item
  77. Hck 2item
  78. RNA Polymerases 2item
  79. MNK 1 item
  80. 5-Lipoxygenases 1 item
  81. Insulin Receptors 1 item
  82. IRG-1R 1 item
  83. Cdc2-like kinase (Clk) 1 item
  84. eEF-2 1 item
  85. Cdc7 1 item
  86. CMV 1 item
  87. ZAP-70 1 item
  88. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  89. Cytidine deaminases 1 item
  90. c-RET 3item
  91. p70 rsk 2item
  92. VEGFR3/FLT4 1 item
  93. NTRK1/TRKA 1 item
  94. CSF-1R/c-Fms 1 item
  95. TAM kinase 1 item
  96. KDR 1 item
  97. Fyn kinase 1 item
  98. Abl kinases 1 item
  99. AXL 1 item
  100. p53 1 item
  101. c-Fms tyrosine kinase 1 item
  102. insulin 1 item
  103. PPAR 1 item
  104. STK 1 item
  105. MSK 1 item
  106. Lyn kinase 1 item
  107. Mer tyrosine kinase 1 item
  108. ErbB-2 1 item
  109. PDK-1 1 item
  110. Histone Acetyltransferases (HATs) 1 item
  111. Prk 1 item
  112. ITK 1 item
  113. NUAK 1 item
  114. DCLK2 1 item
  115. PTK 2item
  116. phosphatidylinositol kinase 1 item
  117. Lck 1 item
  118. prolactin secretion 1 item
  119. gonadotropin release 1 item
  120. Flk1 2item
  121. DNA Ligases 1 item
  122. glutamate release 1 item
  123. FGR 1 item
  124. YES 2item
  125. Fyn 2item
  126. ARG 1 item
  127. TRPC channel 1 item
  128. PKD 1 item
  129. Pyruvate kinases 1 item
  130. enoyl-acyl-carrier protein reductase 1 item
  131. Rho-kinase 1 item
  132. tropomyosin receptor kinase 1 item
  133. SK 1 item
  134. PPK 1 item
  135. c-Syk 1 item
  136. CDK1/CyclinB 1 item
  137. PIM1 kinase 1 item
  138. phospholipase A2 1 item
  139. ATM 1 item
  140. Sirtuin 1 item
  141. PIKfyve 1 item
  142. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 10item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Bladder Cancer 3item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. B-lymphoid Malignancies 1 item
  9. Breast Cancer 27item
  10. Cancer 146item
  11. Cervical Cancer 4item
  12. Cholangiocarcinoma 1 item
  13. Chronic Lymphocytic Leukemia 1 item
  14. Clear Cell Renal Cell Carcinoma 1 item
  15. Colon Cancer 12item
  16. Colon Carcinoma 1 item
  17. Colorectal Cancer 16item
  18. Glioblastoma 10item
  19. Glioma 4item
  20. Hepatocellular Carcinoma 4item
  21. HIV 1 item
  22. HIV Infections 2item
  23. Inflammatory Diseases 1 item
  24. Leukemia 9item
  25. Liver Cancer 2item
  26. Lung Cancer 6item
  27. Lung Carcinoma 1 item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 10item
  31. Multiple Myeloma 3item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Non-small Cell Lung Cancer 4item
  35. Ovarian Cancer 12item
  36. Pancreatic Cancer 14item
  37. Prostate Cancer 10item
  38. Psoriasis 1 item
  39. Renal Cancer 2item
  40. Renal Cell Carcinoma 2item
  41. Rheumatoid Arthritis 4item
  42. Sarcoma 1 item
  43. Squamous Cell Carcinoma 1 item
  44. Thyroid Cancer 3item
  45. Type 2 Diabetes 1 item